Skip to main content

Table 2 Spirometry test results of the PROMPT cohort participants

From: Prevalence and burden of obstructive lung disease in the urban poor population of Ottawa, Canada: a community-based mixed-method, observational study

Mean (SD)

Participants with spirometry

(N = 64)

Participants without OLD (Fixed Ratio) on spirometry

(N = 26)

Participants without OLD (LLN) on spirometry

(N = 35)

Participants with OLD (Fixed Ratio) on spirometry

(N = 38)

Participants with OLD (LLN) on spirometry

(N = 29)

Participants with significant reversibility on spirometry

(N = 10)

FEV1 (L)a

2.80 (1.04)

3.08 (0.90)

3.11 (0.97)

2.61 (1.11)

2.42 (1.02)

1.99 (0.80)

FEV1% Predicted

76.65 (23.64)

89.95 (19.49)

88.52 (19.41)

67.55 (22.04)

3.84 (0.73)

52.91 (17.48)

FVCb (L)

4.15 (1.31)

3.91 (1.13)

4.08 (1.33)

4.32 (1.41)

4.25 (1.30)

3.67 (1.18)

FVC % Predicted

76.75 (23.64)

91.34 (20.96)

91.95 (21.21)

88.12 (17.88)

86.38 (16.01)

77.17 (18.03)

FEV1/FVC

0.68 (0.15)

0.79 (0.06)

0.77 (0.08)

0.60 (0.15)

0.57 (0.15)

0.54 (0.13)

FEV1 Pre- & Post-bronchodilator Difference (L)

−0.13 (0.71)

−0.13 (0.58)

−0.13 (0.56)

−0.13 (0.79)

−0.13 (0.87)

0.69 (0.35)

FEV1 Pre- &Post-bronchodilator Percent Difference (%)

−1.94 (23.29)

−3.49 (17.58)

−2.91 (19.15)

− 0.88 (26.69)

− 0.77 (27.80)

35.54 (12.99)

  1. aFEV1 Forced Expiratory Volume in 1 s
  2. bFVC Forced Vital Capacity